Forbes -
15 Feb 2021 14:00

Covid-19 vaccine stocks have had a stellar run, driven by the urgency to end the pandemic and the unprecedented speed at which companies developed vaccines. So are Covid-19 vaccine stocks still a buy at this juncture?
Share this Article